FILTER

FILTERED INTERVIEW RESULTS

Mining
Canada

Cesar Inostroza

SENIOR VICE-PRESIDENT-MINING AND METALLURGY, SNC-LAVALIN
SNC-Lavalin explains why Québec is well placed to feed the battery metal supply chain.
Mining
Canada

David Cataford

CEO, CHAMPION IRON LIMITED
Champion Iron explains progress at its Bloom Lake iron project in northern Québec.
Mining
Canada

Sandeep Singh

PRESIDENT & CEO, OSISKO GOLD ROYALTIES
Osisko Gold Royalties speaks to GBR of its portfolio of assets in Québec and beyond.
Mining
Chile

Francisco Casas

GENERAL MANAGER, NEXXO
Chile Mining 2021
Nexxo explains how its experience in mechanical maintenance for the petroleum industry is being put to use by Chile’s miners.
Mining
Chile

Fernando Porcile & Eduardo Covarrubias

EXECUTIVE CHAIRMAN & DIRECTOR, LOS ANDES COPPER
Chile Mining 2021
Los Andes Copper updates GBR on progress at its Vizcachitas project in Chile.
Mining
Peru

Antonio Samaniego

DIRECTOR, SRK CONSULTING
SRK Consulting explains the current conditions for mining in Peru.
Mining
Peru

Rik De Buyserie

COUNTRY MANAGER, ENGIE IN PERU & CEO, ENGIE ENERGÍA PERÚ
ENGIE Energía Perú explains how renewable energy is increasingly being adopted by Peru’s mines.
Mining
Canada

Jonatan Julien

MINISTER OF ENERGY AND NATURAL RESOURCES, GOVERNMENT OF QUÉBEC
Québec’s Minister of Energy and Natural Resources explains how the province will play a crucial role in the global energy transition.
Mining
South Africa
MACIG

Peter Steenkamp

CEO, HARMONY
Harmony explains why South African miners are finally feeling more confident.
Mining
South Africa
MACIG

Ralf Hennecke

GENERAL MANAGER - TECHNOLOGY AND MARKETING, BME
BME explains how it is helping South African mines to transition towards smart mining.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL